Twinning treatments

To create transformational combination treatment protocols with PRP and polynucleotides, pair Croma PhilArt Hair with Croma Arthrex ACP

PhilArt is an injectable gel consisting of long-chain polynucleotides (PN). Polynucleotides have a proven safety and efficacy profile with high tolerability and low risk of adverse events, supported by extensive clinical data. Their
use is based on more than 70 years of research and more than 100 published studies presented at national and international congresses.
PhilArt Hair can be utilised as a standalone therapy to support revitalisation of the hair follicles, resulting in promotion and acceleration of the hair growth. It can also be utilised as a Skin Enhancement Technique (SET) to generate synergistic effects and enhance treatment benefits in combination with other interventions (biotin, hyaluronic acid, carboxytherapy, and topical therapy), and as an adjuvant post-surgery treatment after hair transplantation.

The Arthrex ACP double syringe system builds the basis of the Arthrex personalised cell therapy. It enables closed, rapid, and simple production of platelet rich plasma (PRP) which harnesses the body’s own healing and regeneration processes. PRP’s medicinal effect originates from a multitude of growth factors and signalling molecules found in platelets and plasma. No synthetic separation gels or anticoagulants are used as the PRP is separated from the other blood components in a purely physical process. The innovative Arthrex ACP double syringe allows simple preparation of clinically evaluated and proven PRP, without having to compromise on safety and quality.

“We have combined PhilArt with Arthrex ACP as a solution for patients with telogen effluvium or androgenic alopecia. This combination can also be introduced to improve hair quality pre follicle transplant and support growth post-surgery.” Dr Munir Somji
1. Cavallini M, Papagni M. Long Chain Polynucleotides Gel and Skin Biorevitalization. International Journal of Plastic Dermatology-ISPLAD. 2007; 3 (3): 27-32.
2. Cavallini M, Bartoletti E, Maioli L,Massirone A, Pia Palmieri I, Papagni M et al. Consensus report on the use of PN-HPTTM (polynucleotides highly purified technology) in aesthetic medicine. J Cosmet Dermatol. 2021 Mar;20(3):922-928. doi: 10.1111/jocd.13679. Epub 2020 Sep 21. PMID: 32799391; PMCID: PMC7984045
3. Lotti T, Gianfaldoni R, Gianfaldoni S, Nannipieri A. A polynucleotidebased product to treat female hormonal hair loss. Prime Journal 2014; 5(4):2-10.
© Wigmore Medical is a registered pharmacy: no. 1041349